Beth Seidenberg
General Partner·Kleiner Perkins
Beth Seidenberg is the founding managing director of Westlake Village BioPartners and was a general partner at Kleiner Perkins, where she focused on life sciences. She has incubated and invested in more than 40 biotech companies since 2005 and serves on public company boards including Acelyrin, Kyverna, Progyny, Sagimet and Vera. Before investing, she held leadership roles in drug development at Amgen, Bristol Myers Squibb and Merck.
See the rest of Beth Seidenberg's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.